Oxford, United Kingdom

Richard Mark Edwards

USPTO Granted Patents = 11 

Average Co-Inventor Count = 3.0

ph-index = 6

Forward Citations = 136(Granted Patents)


Location History:

  • Oxon, GB (1993)
  • Thame, GB (1993 - 1997)
  • Oxford, GB (1996 - 2005)

Company Filing History:


Years Active: 1993-2005

Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovations of Richard Mark Edwards

Introduction

Richard Mark Edwards is a notable inventor based in Oxford, GB. He has made significant contributions to the field of biotechnology, holding a total of 11 patents. His work primarily focuses on the development of innovative proteins and their applications in medical science.

Latest Patents

Among his latest patents is the invention of fusion proteins between antigenic amino acid sequences and beta-2-microglobulin. This hybrid fusion protein comprises a first antigenic amino acid sequence fused to a second amino acid sequence that is substantially homologous to B2M or a fragment thereof. Another significant patent involves stem cell inhibiting proteins, which have potential applications in various therapeutic areas.

Career Highlights

Throughout his career, Richard has worked with prominent companies in the biotechnology sector, including British Biotech Pharmaceuticals Limited and British Bio-technology Limited. His expertise and innovative approach have positioned him as a key figure in the development of new biopharmaceuticals.

Collaborations

Richard has collaborated with several professionals in his field, including Michael George Hunter and Stewart Craig. These partnerships have further enhanced his research and development efforts.

Conclusion

Richard Mark Edwards continues to be a driving force in biotechnology through his innovative patents and collaborations. His work has the potential to impact various medical fields significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…